Buy JB Chemicals; target of Rs 250: Sunidhi Securities

JBCPL plans to continue to pursue focus on harnessing the potential of the existing products basket, selective new product launches and increase in productivity. The company is fully focused on this business, which has significant value potential. JBCPL plans to invest about Rs140 crore in the new capacity and related infrastructure in the next 12-18 months through internal accruals. JBCPL, one of India’s leading pharmaceutical companies, manufactures & markets a diverse range of pharmaceutical formulations, herbal remedies and APIs. JBCPL is widely committed to manufacturing a range of innovative specialty products that include various pharmaceutical dosage forms like tablets, injectable (vials, ampoules, form fill seal), creams & ointments, lozenges, herbal liquids and capsules. ANDAs, contract manufacturing in tablets, lozenges & injectables, branded generics, lozenges and contrast media products remain the focus area, while in terms of market, the company’s focus is on US, South Africa, UK, Canada, Australia and several semi-regulated markets.

Read more at: http://www.moneycontrol.com/news/recommendations/buy-jb-chemicals-targetrs-250-sunidhi-securities_1150229.html?utm_source=ref_article